Search for: "WATSON PHARMACEUTICALS "
Results 181 - 200
of 359
Sorted by Relevance
|
Sort by Date
25 Jun 2012, 2:01 pm
The Judicial Panel will also consider requests to establish several new MDLs and transfer cases: MDL No. 2372 - Fentanyl Patch cases against Watson - Request has been made to transfer 11 cases pending in federal courts in Arizona, Florida, Kentucky, Maryland, and Missouri to the federal court in Chicago. [read post]
25 Jun 2012, 2:01 pm
The Judicial Panel will also consider requests to establish several new MDLs and transfer cases: MDL No. 2372 - Fentanyl Patch cases against Watson - Request has been made to transfer 11 cases pending in federal courts in Arizona, Florida, Kentucky, Maryland, and Missouri to the federal court in Chicago. [read post]
10 May 2011, 4:24 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
24 Jan 2007, 9:59 pm
It was also recently reported that Lek D.D., a subsidiary of Sandoz, filed a complaint for patent infringement against Bristol-Myers Squibb and Watson Pharmaceuticals relating to BMS's Pravachol (pravastatin sodium). [read post]
24 Nov 2009, 1:11 am
., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
24 Nov 2009, 1:11 am
., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and Ortho-McNeil Janssen Pharmaceuticals Inc. [read post]
27 Jun 2010, 10:37 pm
It targets the companies Pliva Pharmaceuticals, Barr Laboratories, Teva Pharmaceuticals and Watson Pharmaceuticals — all are generic manufacturers of Reglan. [read post]
15 Aug 2012, 11:02 am
According to Watson, “[b]ased on the simultaneous filing of the Watson ANDA with Mylan and Ranbaxy’s ANDAs, Watson has expected to share the period of 180-day exclusivity with Mylan and Ranbaxy (as well as with a fourth generic manufacturer, Teva Pharmaceuticals (‘Teva’), that has been granted a license by Takeda). [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
25 Apr 2012, 1:56 pm
Watson Pharmaceuticals, Inc., No. 10-12729, is available here. [read post]
5 Apr 2017, 9:08 am
With respectto Watson, the PTAB found that it “does not controlhere because [Appellee] Noven [Pharmaceuticals Inc. [read post]
26 Jan 2015, 10:37 am
Watson Pharma. [read post]
29 Feb 2012, 3:28 am
Watson Pharmaceuticals, Inc., et. al., 3-11-cv-00481 (NVD February 24, 2012, Order) (Jones, J.) [read post]
19 Jan 2011, 2:44 pm
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
15 May 2011, 9:07 pm
UPDATE: On May 16, Watson Pharmaceuticals announced that it launched an authorized generic version of Amrix, supplied by Cephalon's Anesta AG subsidiary. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
14 Nov 2007, 4:51 am
Defense attorneys moved to dismiss the class action against Watson Pharmaceuticals on the ground that it failed to plead fraud with the specificity required under the PSLRA; the district court granted the motion. [read post]
